Correction
Published on 13 May 2022
Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.903766
- 1,822 views
- 2 citations
Type at least 3 characters
362 articles
Case Report
Published on 12 May 2022
Successful Therapy for Myocarditis Concomitant With Complete Heart Block After Pembrolizumab Treatment for Head and Neck Squamous Cell Carcinoma: A Case Report With Literature Review
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.898756
- 4,100 views
- 17 citations
Correction
Published on 10 May 2022
Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.920605
- 1,069 views
Review
Published on 25 Apr 2022
Etiology and Management of Dyslipidemia in Patients With Cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.892335
- 9,943 views
- 21 citations
Review
Published on 22 Apr 2022
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.863314
- 13,080 views
- 32 citations
Review
Published on 21 Apr 2022
Genetics of Anthracycline-Associated Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867873
- 5,867 views
- 21 citations
Review
Published on 15 Apr 2022
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.858334
- 7,357 views
- 27 citations
Review
Published on 15 Apr 2022
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.847012
- 25,400 views
- 104 citations
Original Research
Published on 15 Apr 2022
Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.739044
- 8,104 views
- 22 citations
Systematic Review
Published on 14 Apr 2022
Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867002
- 4,208 views
- 14 citations
Original Research
Published on 14 Apr 2022
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867867
- 3,181 views
- 11 citations
Original Research
Published on 13 Apr 2022
Long-Term Risk of Death From Heart Disease Among Breast Cancer Patients
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.784409
- 6,030 views
- 12 citations
Original Research
Published on 11 Apr 2022
Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.833649
- 4,189 views
- 5 citations
Original Research
Published on 07 Apr 2022
Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.821267
- 4,198 views
- 15 citations
Case Report
Published on 04 Apr 2022
Case Report: Systemic Amyloidosis Involving the Heart and Skeletal Muscle
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.816236
- 4,634 views
Original Research
Published on 25 Mar 2022
Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.742193
- 4,449 views
- 7 citations